Transient seizure activity induced by acetylcarnitine.

Area of Science:

• Neuroscience
• Epileptology
• Pharmacology

Background:

• Epilepsy is a neurological disorder characterized by recurrent seizures.
• Understanding the neurochemical mechanisms underlying seizure generation is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the epileptogenic properties of L-acetylcarnitine and L-carnitine in a rat model.
• To explore the potential involvement of muscarinic and GABAergic systems in L-acetylcarnitine-induced epilepsy.

Main Methods:

• Intracerebral injections of L-acetylcarnitine and L-carnitine in rats.
• Administration of atropine (muscarinic antagonist), muscimol, and THIP (GABA agonists) to assess their effects on induced epileptic phenomena.
• Electrophysiological monitoring to record interictal and ictal epileptic events.

Main Results:

• Intracerebral L-acetylcarnitine induced immediate interictal and ictal epileptic phenomena lasting up to 4 hours.
• Systemic atropine pretreatment completely prevented L-acetylcarnitine-induced epileptiform activity.
• Local muscimol and THIP injections abolished ictal events but not interictal spikes, while L-carnitine induced delayed ictal discharges.

Conclusions:

• L-acetylcarnitine exhibits potent epileptogenic properties, likely mediated by muscarinic receptor agonism.
• The transition from interictal to ictal epileptic events may involve the failure of GABAergic inhibitory mechanisms.
• These findings highlight the potential role of cholinergic and GABAergic systems in seizure pathophysiology.